Upgrade to SI Premium - Free Trial

UBS Reiterates Buy on CME Group (CME) Following 2Q

July 29, 2016 8:48 AM
UBS reiterated a Buy rating on CME Group (NASDAQ: CME), and raised the price target to $114.00 (from $104.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles